UPWARDS Training Program (Underrepresented Minorities Working Towards Research Diversity in Science)
UPWARDS 培训计划(代表性不足的少数族裔致力于科学研究多样性)
基本信息
- 批准号:10023785
- 负责人:
- 金额:$ 41.96万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-09-03 至 2025-08-31
- 项目状态:未结题
- 来源:
- 关键词:AddressAdmission activityBachelor&aposs DegreeBioethicsCancer BiologyCancer CenterCareer ChoiceCareer ExplorationChildhoodCommunicationCommunitiesCommunity Health EducationCommunity OutreachComplementDataDevelopmentDevelopment PlansDoctor&aposs DegreeEarly InterventionEconomicsEducationEnrollmentExposure toFacultyFeedbackFosteringGenerationsGoalsGraduate EducationHealth Care ResearchImmersionIndividualKnowledgeLaboratory ResearchLeadLearningMentorsMinorityMissionOralOutcomePeer ReviewPositioning AttributePrevention educationProcessPublicationsResearchResearch TrainingRoleSTEM careerScienceScience, Technology, Engineering and Mathematics EducationScientistStudentsSupport SystemTimeTrainingTraining ProgramsUnderrepresented MinorityUnderrepresented Studentsanticancer researchbasecancer carecancer health disparitycancer preventioncareercareer awarenesscareer developmentdesigneducation researchexperiencefaculty mentorfamily supporthands on researchhigh schoolhigh school programinnovationinterestintervention programminority communitiesminority scientistminority studentminority undergraduatenoveloutreachposterspreventprogramspublic health relevancerecruitresponsible research conductskill acquisitionskillsstudent trainingsuccesssummer researchundergraduate student
项目摘要
PROJECT SUMMARY/ABSTRACT
As a recognized leader in cancer research,1 MD Anderson Cancer Center is well poised to address a
significant lack of diversity in the cancer research workforce that contributes to considerable disparities.2-6 We
will do so via early intervention programs that foster sustained interest in cancer research in students
underrepresented and minority in Science (URMS). Since 2011, we have directed a summer undergraduate
training program encompassing 345 trainees (from 2011-2018), including 120 URMS. Significantly, outcomes
for URMS and non-minority trainees in our program are indistinguishable; URMS and non-minority alumni are
enrolled in or have completed STEM bachelor’s (98.8% vs 98.1%) and doctoral (both 67.1%) degrees and are
retained in STEM education or workforce (98.3% vs 98.6%, respectively). Built upon these successes, we have
designed a comprehensive cancer research training program for high school and undergraduate URMS via the
R25 YES initiative. In our URMS-focused program, we address major barriers in URMS pursuit and success in
STEM, including: limited 1) research experience, 2) career path knowledge, and 3) scientific identity formation
and exposure to science; 4) underdeveloped professionalism and communication skills; 5) inadequate
research, educational, and career mentoring; and 6) barriers in the graduate application process. Our
proposed UPWARDS Training Program (Underrepresented Minorities Working Towards Research Diversity in
Science) has 3 tracks: full-time, 12-week summer research for 1) high-schoolers and 2) undergraduates and 3)
part-time, 40-week research for undergraduates. Within each track, we propose the following aims to address
the aforementioned barriers: Aim 1) Employ focused URMS recruitment and holistic strategies for program
inclusion, and deliver didactic learning and hands-on cancer research experiences through a cadre of
outstanding mentoring faculty. Aim 2) Develop and deliver individualized mentoring, career exploration,
and professional development that stimulates graduate education and cancer research career pursuit.
Aim 3) Educate and inspire URMS communities, young generations in the STEM pipeline, and the
families and support systems of our students through training, STEM outreach, and hands-on
engagement. We will encourage our trainees to lead and encourage their communities and younger
generations through hands-on STEM outreach activities and design and delivery of community education.
Aim 4) Implement and maintain a rigorous assessment program with continual appraisal and enactment of
novel, evidence-driven best practices derived from these efforts. Lastly, we commit to disseminating our
findings and best practices via peer-reviewed publications. Through the UPWARDS Program, we will build
upon our prior experiences and best practices to launch a cancer research training program specifically
designed to fit the needs of URMS trainees in our local community and nationally. We anticipate our efforts will
effectively increase diversity in the STEM educational pipeline and cancer research workforce.
项目总结/摘要
作为癌症研究领域公认的领导者,1 MD安德森癌症中心已做好准备,
癌症研究人员严重缺乏多样性,这导致了相当大的风险。
我将通过早期干预项目来实现这一目标,这些项目将培养学生对癌症研究的持续兴趣
在科学领域代表性不足和少数民族(URMS)。自2011年以来,我们已经指导了一个夏季本科生
培训计划包括345名受训人员(2011-2018年),其中包括120名URMS。重要的是,结果
在我们的计划URMS和非少数民族学员是无法区分的; URMS和非少数民族校友是
就读或完成STEM学士(98.8%对98.1%)和博士(均为67.1%)学位,
保留在STEM教育或劳动力中(分别为98.3%和98.6%)。在这些成功的基础上,
为高中和本科URMS设计了一个全面的癌症研究培训计划,
R25 YES倡议。在我们的URMS为重点的计划,我们解决URMS追求和成功的主要障碍,
STEM,包括:1)有限的研究经验,2)职业道路知识,3)科学身份的形成
4)专业精神和沟通技能不发达; 5)不充分
研究,教育和职业指导;和6)研究生申请过程中的障碍。我们
UPWARDS培训计划(代表性不足的少数民族致力于研究多样性,
科学)有3个轨道:全职,12周的夏季研究1)高中生和2)本科生和3)
为本科生进行为期40周的兼职研究。在每个轨道内,我们提出以下目标,以解决
上述障碍:目标1)采用有针对性的URMS招聘和整体战略,
包容性,并提供教学学习和动手癌症研究的经验,通过干部,
优秀的导师目标2)开发和提供个性化的指导,职业探索,
和专业发展,刺激研究生教育和癌症研究的职业追求。
目标3)教育和激励URMS社区,STEM管道中的年轻一代,
家庭和我们的学生通过培训,STEM外展和动手支持系统
订婚我们将鼓励我们的学员领导和鼓励他们的社区和年轻人,
通过动手STEM外展活动以及设计和提供社区教育,为几代人提供培训。
目标4)实施和维护严格的评估计划,持续评估和制定
从这些努力中产生的新颖的、以证据为导向的最佳做法。最后,我们致力于传播我们的
通过同行评审的出版物提供调查结果和最佳做法。通过UPWARDS计划,我们将建立
根据我们以前的经验和最佳实践,专门推出癌症研究培训计划,
旨在满足我们当地社区和国家的URMS学员的需求。我们预计我们的努力将
有效地增加STEM教育管道和癌症研究人员的多样性。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
KHANDAN KEYOMARSI其他文献
KHANDAN KEYOMARSI的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('KHANDAN KEYOMARSI', 18)}}的其他基金
Targeting STAT3 for the Treatment of CDK4/6 Inhibitor Resistant Advanced Estrogen Receptor Positive Breast Cancer Patients
靶向 STAT3 治疗 CDK4/6 抑制剂耐药的晚期雌激素受体阳性乳腺癌患者
- 批准号:
10316167 - 财政年份:2020
- 资助金额:
$ 41.96万 - 项目类别:
UPWARDS Training Program (Underrepresented Minorities Working Towards Research Diversity in Science)
UPWARDS 培训计划(代表性不足的少数族裔致力于科学研究多样性)
- 批准号:
10252909 - 财政年份:2020
- 资助金额:
$ 41.96万 - 项目类别:
Targeting STAT3 for the Treatment of CDK4/6 Inhibitor Resistant Advanced Estrogen Receptor Positive Breast Cancer Patients
靶向 STAT3 治疗 CDK4/6 抑制剂耐药的晚期雌激素受体阳性乳腺癌患者
- 批准号:
10097489 - 财政年份:2020
- 资助金额:
$ 41.96万 - 项目类别:
Cytoplasmic cyclin E is an early event for progression to invasive breast cancer
细胞质周期蛋白 E 是进展为浸润性乳腺癌的早期事件
- 批准号:
10550153 - 财政年份:2018
- 资助金额:
$ 41.96万 - 项目类别:
Cytoplasmic cyclin E is an early event for progression to invasive breast cancer
细胞质周期蛋白 E 是进展为浸润性乳腺癌的早期事件
- 批准号:
9436336 - 财政年份:2018
- 资助金额:
$ 41.96万 - 项目类别:
Cytoplasmic cyclin E is an early event for progression to invasive breast cancer
细胞质周期蛋白 E 是进展为浸润性乳腺癌的早期事件
- 批准号:
10337331 - 财政年份:2018
- 资助金额:
$ 41.96万 - 项目类别:
Cytoplasmic cyclin E is an early event for progression to invasive breast cancer
细胞质周期蛋白 E 是进展为浸润性乳腺癌的早期事件
- 批准号:
10113558 - 财政年份:2018
- 资助金额:
$ 41.96万 - 项目类别:
Targeting the cell cycle in triple negative breast cancer
靶向三阴性乳腺癌的细胞周期
- 批准号:
8250334 - 财政年份:2011
- 资助金额:
$ 41.96万 - 项目类别:
Targeting the cell cycle in triple negative breast cancer
靶向三阴性乳腺癌的细胞周期
- 批准号:
8631060 - 财政年份:2011
- 资助金额:
$ 41.96万 - 项目类别:
Targeting the cell cycle in triple negative breast cancer
靶向三阴性乳腺癌的细胞周期
- 批准号:
8454512 - 财政年份:2011
- 资助金额:
$ 41.96万 - 项目类别:














{{item.name}}会员




